Withdrawal of Rosiglitazone and Sibutramine Enforced
Following a series of tests that show harmful effects of the known anti-diabetes drug rosiglitazone and anti-obesity drug sibutramine, respective manufacturers and health agencies abroad ordered the withdrawal of these two drugs in the world-wide market. Related terms:sibutramine 2011sibutramine in Philippinephilippine fda sibutraminesibutramine withdraw philippinesavailability of sibutramine in philippinessibutramine philippinessibutramine in philippinessibutramine diabetessibutramine 2012rosiglitazone withdrawal […]